TY - JOUR
T1 - Examples of implementation and evaluation of treatment fidelity in the BCC Studies
T2 - Where we are and where we need to go
AU - Resnick, Barbara
AU - Bellg, Albert J.
AU - Borrelli, Belinda
AU - DeFrancesco, Carol
AU - Breger, Rosemary
AU - Hecht, Jacki
AU - Sharp, Daryl L.
AU - Levesque, Chantal
AU - Orwig, Denise
AU - Ernst, Denise
AU - Ogedegbe, Gbenga
AU - Czajkowski, Susan
N1 - Funding Information:
The Behavior Change Consortium (BCC) is a group of 15 projects funded by the National Institutes of Health and investigating mechanisms of health behavior change (7). The treatment fidelity workgroup (TxFW) was formed within this consortium
PY - 2005
Y1 - 2005
N2 - Treatment fidelity plays an important role in the research team's ability to ensure that a treatment has been implemented as intended and that the treatment has been accurately tested. Developing, implementing, and evaluating a treatment fidelity plan can be challenging. The treatment fidelity workgroup within the Behavior Change Consortium (BCC) developed guidelines to comprehensively evaluate treatment fidelity in behavior change research. The guidelines include evaluation of treatment fidelity with regard to study design, training of interventionists, delivery and receipt of the intervention, and enactment of the intervention in real-life settings. This article describes these guidelines and provides examples from four BCC studies as to how these recommended guidelines for fidelity were considered. Future work needs to focus not only on implementing treatment fidelity plans but also on quantifying the evaluations performed, developing specific criteria for interpretation of the findings, and establishing best practices of treatment fidelity.
AB - Treatment fidelity plays an important role in the research team's ability to ensure that a treatment has been implemented as intended and that the treatment has been accurately tested. Developing, implementing, and evaluating a treatment fidelity plan can be challenging. The treatment fidelity workgroup within the Behavior Change Consortium (BCC) developed guidelines to comprehensively evaluate treatment fidelity in behavior change research. The guidelines include evaluation of treatment fidelity with regard to study design, training of interventionists, delivery and receipt of the intervention, and enactment of the intervention in real-life settings. This article describes these guidelines and provides examples from four BCC studies as to how these recommended guidelines for fidelity were considered. Future work needs to focus not only on implementing treatment fidelity plans but also on quantifying the evaluations performed, developing specific criteria for interpretation of the findings, and establishing best practices of treatment fidelity.
UR - http://www.scopus.com/inward/record.url?scp=17844395119&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=17844395119&partnerID=8YFLogxK
U2 - 10.1207/s15324796abm2902s_8
DO - 10.1207/s15324796abm2902s_8
M3 - Article
C2 - 15921489
AN - SCOPUS:17844395119
SN - 0883-6612
VL - 29
SP - 46
EP - 54
JO - Annals of Behavioral Medicine
JF - Annals of Behavioral Medicine
IS - SUPPL.
ER -